Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$106.4M
+18.8% from 2023
Prescriptions
4,809
$22,132.68 per claim
Patients
1,048
1,015 prescribers
Total spending, 2024
$106.4M
$101,561.13 per patient
Medicare prescription drug plans paid $106.4M for Xospata in 2024, for 4,809 prescriptions and refills to 1,048 patients (up 18.8% from 2023). The average cost per claim was $22,132.68.
California had the highest Medicare cost for Xospata in 2024: $11.2M for 481 claims, followed by Pennsylvania ($8.9M).
Mark Levis, medical oncology in Baltimore, MD, had the highest Medicare cost for Xospata in 2024: 92 claims costing $2.3M.
Xospata is made by Astellas Pharma Inc. (4503.T), listed in the Medicare spending data as Astellas Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mark Levis Baltimore, MD | Medical Oncology | 92 | 12 | $2.3M |
| Kaitlin A Rancani Philadelphia, PA | Nurse Practitioner | 41 | Under 11 | $1.0M |
| Shannon R McCurdy |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 744 | 3,247 | 789 | $75.6M |
| 2023 | 903 | 3,876 | 923 | $89.6M |
| 2024 | 1,015 | 4,809 | 1,048 | $106.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 30 |
| Under 11 |
| $843K |
| David A Sallman Tampa, FL | Internal Medicine | 36 | 11 | $797K |
| Kimberly M Green Columbus, OH | Hematopoietic Cell Transplantation and Cellular Therapy | 28 | Under 11 | $653K |
| Konstantinos Sdrimas Morgantown, WV | Internal Medicine | 25 | Under 11 | $652K |
| Devendra Kc Hartford, CT | Medical Oncology | 27 | Under 11 | $612K |
| Zachary D Crees Saint Louis, MO | Medical Oncology | 36 | Under 11 | $606K |
| Joshua F Zeidner Chapel Hill, NC | Hematology-Oncology | 22 | Under 11 | $602K |
| Marlise R Luskin Boston, MA | Internal Medicine | 21 | Under 11 | $598K |
| David Swoboda Tampa, FL | Hematology | 28 | Under 11 | $596K |
| Haris Ali Duarte, CA | Hematology | 25 | Under 11 | $587K |
| Neil D Palmisiano Sewell, NJ | Medical Oncology | 25 | Under 11 | $582K |
| Rafic Farah Seattle, WA | Hematology-Oncology | 26 | Under 11 | $535K |
| Hassan Alkhateeb Rochester, MN | Hematology | 31 | Under 11 | $527K |
| Myles S Nickolich Hershey, PA | Hematology-Oncology | 18 | Under 11 | $498K |
| Rebecca Olin San Francisco, CA | Hematology-Oncology | 26 | Under 11 | $491K |
| Alison W Loren Philadelphia, PA | Hematology-Oncology | 17 | Under 11 | $487K |
| James K Mangan San Diego, CA | Hematology-Oncology | 22 | Under 11 | $474K |
| Kristen M Pettit Ann Arbor, MI | Hematology | 16 | Under 11 | $449K |
| Meredith L Saylor Boston, MA | Nurse Practitioner | 20 | Under 11 | $448K |
| Steven C Tsai Santa Monica, CA | Hematology-Oncology | 24 | Under 11 | $446K |
| Elizabeth H Schonhoft Boston, MA | Nurse Practitioner | 16 | Under 11 | $437K |
| Joseph Cioccio Hershey, PA | Internal Medicine | 18 | Under 11 | $421K |
| Christine M McMahon Aurora, CO | Hematology-Oncology | 16 | Under 11 | $415K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astellas Pharma 4503.T | 4,809 | $106.4M |